Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intervertebral Disc Regeneration by Autologous Stem Cell Transplantation
2024-514475-17-00Phase 2Authorised
- Sponsor
- Aarhus University
- Start
- Oct 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in degenerative disc disease (DDD) (2 arms), sponsored by Aarhus University. Primary endpoints: Treatment success and safety, Visual Analog Scale (VAS) pain score and 5 more. Planned start Oct 2024; status: authorised.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on 2024-514475-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514475-17-00.